Allstate Corporation’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Sell
10,584
-18,570
-64% -$725K 0.01% 987
2026
Q1
$1.03M Buy
+29,154
New +$904K 0.01% 805

Other funds holding ALKS

Allstate Corporation's ALKS Position: Q2 2026 in Review

Allstate Corporation reduced its Alkermes (ALKS) stake by 64% in Q2 2026, selling an estimated $725K and leaving 10,584 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #987.

Allstate Corporation first reported a position in ALKS in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.03M in Q1 2026. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Allstate Corporation held 10,584 shares of Alkermes worth $555K as of Q2 2026.
  • Allstate Corporation sold 18,570 Alkermes shares in Q2 2026, an estimated $725K.
  • Alkermes made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #987 holding.
  • Allstate Corporation first reported a position in Alkermes in Q1 2026 and has held it in 2 quarters since.
  • Allstate Corporation's Alkermes position peaked at $1.03M in Q1 2026.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.